Get started
Author

Gopika Krishnan

Observed names: G. Krishnan, GOPIKA KRISHNAN
Observed institutions: Amrita Institute of Medical Sciences and Research Centre, Government Medical College, Christian Medical College, Vellore, Medical College of Wisconsin, Government Medical College, Fortis Healthcare, Lilavati Hospital & Research Centre, Apollo Gleneagles Hospitals, Madras Diabetes Research Foundation, Government Medical College and Hospital, Diacon Hospital, Diabetes Care & Hormone Clinic, Jothydev's Diabetes and Research Center, Dr. Mohan's Diabetes Specialities Centre, Bhatia Hospital, All India Institute of Medical Sciences Guwahati, Assam Science and Technology University, Assam Science Technology and Environment Council, Jawaharlal Institute of Post Graduate Medical Education and Research, Amrita Vishwa Vidyapeetham, Osmania Medical College
ORCID: 0000-0002-4565-8549
Observed ORCID: 0000-0002-4565-8549
OpenAlex ID: A5111288428
Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas
2020 · Jothydev Kesavadev, Banshi Saboo, et al. · Diabetes Therapy · 236
PDF
Human Digital Twin for Personalized Elderly Type 2 Diabetes Management
2023 · Padmapritha Thamotharan, Seshadhri Srinivasan, et al. · Journal of Clinical Medicine · 98
PDF
The Do-It-Yourself Artificial Pancreas: A Comprehensive Review
2020 · Jothydev Kesavadev, Seshadhri Srinivasan, et al. · Diabetes Therapy · 95
PDF
Cost-Effective Use of Telemedicine and Self-Monitoring of Blood Glucose via Diabetes Tele Management System (DTMS) to Achieve Target Glycosylated Hemoglobin Values Without Serious Symptomatic Hypoglycemia in 1,000 Subjects with Type 2 Diabetes Mellitus—A Retrospective Study
2012 · Jothydev Kesavadev, Arun Shankar, et al. · Diabetes Technology & Therapeutics · 70
Digital health and diabetes: experience from India
2021 · Jothydev Kesavadev, Gopika Krishnan, et al. · Therapeutic Advances in Endocrinology and Metabolism · 62
PDF
Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
2015 · Jothydev Kesavadev, Banshi Saboo, et al. · Indian Journal of Endocrinology and Metabolism · 45
Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation
2017 · Jothydev Kesavadev, Robert Vigersky, et al. · Advances in Therapy · 42
Time-in-range as a target in type 2 diabetes: An urgent need
2021 · Banshi Saboo, Jothydev Kesavadev, et al. · Heliyon · 41
PDF
Use of Insulin Pumps in India: Suggested Guidelines Based on Experience and Cultural Differences
2010 · Jothydev Kesavadev, Ashok Kumar Das, et al. · Diabetes Technology & Therapeutics · 40
Suggested use of vaccines in diabetes
2012 · Jothydev Kesavadev, Anoop Misra, et al. · Indian Journal of Endocrinology and Metabolism · 39
COVID-19 associated mucormycosis: A Descriptive Multisite Study from India
2021 · Ritesh Gupta, Jothydev Kesavadev, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 26
PDF
A new interventional home care model for COVID management: Virtual Covid IP
2021 · Jothydev Kesavadev, Anjana Basanth, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 26
PDF
Liraglutide therapy beyond glycemic control: An observational study in Indian patients with type 2 diabetes in real world setting
2012 · Jothydev Kesavadev, Arun Shankar, et al. · International Journal of General Medicine · 22
PDF
Glucose monitoring technologies - complementary or competitive? Role of continuous glucose monitoring versus flash glucose monitoring versus self-monitoring of blood glucose
2017 · Jothydev Kesavadev, Lakshmy Ramachandran, et al. · Journal of Diabetology · 20
Our First 825 T2DM Patients on 14-Day Factory-Calibrated Glucose Monitoring System: Clinical Utility and Challenges
2017 · Jothydev Kesavadev, Arun Shankar, et al. · Journal of Diabetes Science and Technology · 17
PDF
Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
2023 · Jothydev Kesavadev, Anjana Basanth, et al. · Diabetes Therapy · 16
PDF
Smart Artificial Pancreas with Diet Recommender System for Elderly Diabetes
2020 · T. Padmapritha, B. Subathra, et al. · IFAC-PapersOnLine · 10
Exploratory CSII Randomized Controlled Trial on Erectile Dysfunction in T2DM Patients (ECSIITED)
2018 · Jothydev Kesavadev, Pradeep Babu Sadasivan Pillai, et al. · Journal of Diabetes Science and Technology · 10
PDF
The two levels of care for diabetes in a developing country: Mechanisms for improved intermediate health outcomes
2015 · Rebecca J. Vitale, Pradeep B. Pillai, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 10
CSII as an Alternative Therapeutic Strategy for Managing Type 2 Diabetes: Adding the Indian Experience to a Global Perspective
2016 · Jothydev Kesavadev, Arun Shankar, et al. · Current Diabetes Reviews · 9
An Overview of Currently Available Injectable Therapies in Diabetes: A Guide to Practitioners
2025 · Jothydev Kesavadev, Anjana Basanth, et al. · Advances in Therapy · 8
PDF
880-P: Is Time-in-Range Independent of A1C? A Study in Asian Indian Population
2020 · JOTHYDEV KESAVADEV, ARUN SHANKAR, et al. · Diabetes · 7
Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)
2017 · Jothydev Kesavadev, Pradeep Babu Sadasivan Pillai, et al. · Endocrine Connections · 7
PDF
The Significance of Repeated Education in Correcting Insulin Injection Techniques and Improving Glycemic Control
2022 · Gopika Krishnan, Jothydev Kesavadev, et al. · International Journal of Diabetes and Technology · 6
The Historical Evolution of Continuous Glucose Monitoring - The Story of 25 Years
2023 · Jothydev Kesavadev, Banshi Saboo, et al. · International Journal of Diabetes and Technology · 5
Works count: 82
Citation count: 1,029
H-index: 16
I10-index: 19
Year
Topic
Type